Log in to search using one of your social media accounts:

Quality of care for peripheral artery disease is low
This study is a “call to action” to identify and implement effective physician-targeted and patient-targeted strategies aimed at improving quality of care. These strategies should take advantage of recent advances in behavior change, including leveraging an individual’s social support network to help them mak e lifestyle changes, and providing physicians with feedback about the quality of care they provide to patients with peripheral artery disease.AUTHORSJoseph Ladapo of UCLA and Jeffrey Berger of New York University.JOURNALThe studyis published online by the Journal of the American College of Cardi...
Source: UCLA Newsroom: Health Sciences - May 1, 2017 Category: Universities & Medical Training Source Type: news

Cilostazol: An Option for Ischemic Stroke After ICH? Cilostazol: An Option for Ischemic Stroke After ICH?
The antiplatelet agent cilostazol showed promising results among this difficult-to-treat group in the PICASSO trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 2, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Cilostazol Fails to Best Aspirin for Post-Stroke Secondary Prevention (CME/CE)
(MedPage Today) -- Non-inferior overall but MI rates higher with PDE3 inhibitor (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 25, 2017 Category: Geriatrics Source Type: news

CILOSTAZOL Tablet [NuCare Pharmaceuticals, Inc.]
Updated Date: Feb 9, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - February 9, 2017 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [NuCare Pharmaceuticals,Inc.]
Updated Date: Feb 9, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - February 9, 2017 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Lake Erie Medical DBA Quality Care Products LLC]
Updated Date: Jan 12, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - January 12, 2017 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [BioKey, Inc.]
Updated Date: Jan 3, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - January 3, 2017 Category: Drugs & Pharmacology Source Type: news

Pletal (Cilostazol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 26, 2016 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [West-Ward Pharmaceuticals Corp.]
Updated Date: Jul 6, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - July 6, 2016 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Avera McKennan Hospital]
Updated Date: Mar 1, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - March 1, 2016 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Avera McKennan Hospital]
Updated Date: Dec 18, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - December 18, 2015 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Eon Labs, Inc.]
Updated Date: Oct 28, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 28, 2015 Category: Drugs & Pharmacology Source Type: news

Cilostazol Bridges Surgical DES Patients Without DAPTCilostazol Bridges Surgical DES Patients Without DAPT
Based on long-term follow-up in an observational study, the PDE-3 inhibitor was called an "ingenious bridge" for patients taken off standard dual-antiplatelet therapy during surgery. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 11, 2015 Category: Cardiology Tags: Cardiology News Source Type: news

CILOSTAZOL Tablet [Golden State Medical Supply, Inc.]
Updated Date: May 5, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - May 5, 2015 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Golden State Medical Supply, Inc.]
Updated Date: Mar 30, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - March 30, 2015 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Apotex Corp.]
Updated Date: Mar 13, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - March 13, 2015 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Roxane Laboratories, Inc]
Updated Date: Mar 5, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - March 5, 2015 Category: Drugs & Pharmacology Source Type: news

Pletal (Cilostazol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 13, 2015 Category: Drugs & Pharmacology Source Type: news

PLETAL (Cilostazol) Tablet [Otsuka America Pharmaceutical, Inc.]
Updated Date: Feb 9, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 9, 2015 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Carilion Materials Management]
Updated Date: Aug 15, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 15, 2014 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [American Health Packaging]
Updated Date: Aug 11, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 11, 2014 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Preferred Pharmaceuticals, Inc.]
Updated Date: Jul 31, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 31, 2014 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [Teva Pharmaceuticals USA Inc]
Updated Date: Jul 24, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 24, 2014 Category: Drugs & Pharmacology Source Type: news

CILOSTAZOL Tablet [BIOKEY INC.]
Updated Date: Apr 1, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - April 1, 2014 Category: Drugs & Pharmacology Source Type: news

Two Antiplatelet Add-on Regimens About Equal (CME/CE)
(MedPage Today) -- Adding cilostazol (Pletal) to standard dual antiplatelet therapy performed as well as doubling the dose of clopidogrel (Plavix) after implantation of a drug-eluting stent, the HOST-ASSURE study showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 17, 2013 Category: Cardiology Source Type: news

EMA recommends restricting cilostazol use for PAD
The Europeans Medicines Agency has recommended restricting the use of cilostazol in patients with intermittent claudication. Use should be avoided in those with cardiac problems or on dual anticoagulants. (Source: theHeart.org)
Source: theHeart.org - March 22, 2013 Category: Cardiology Source Type: news

EMA Recommends Restricting Cilostazol Use for PADEMA Recommends Restricting Cilostazol Use for PAD
The Europeans Medicines Agency has recommended restricting the use of cilostazol in patients with intermittent claudication. Use should be avoided in those with cardiac problems or on dual anticoagulants News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 22, 2013 Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news

EU medicines agency to restrict use of Otsuka drug
LONDON (Reuters) - The European Medicines Agency said on Friday it was recommending restricting the use of medicines containing cilostazol, sold by Otsuka under the brand name Pletal, following concerns over side effects. (Source: Reuters: Health)
Source: Reuters: Health - March 22, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

European Medicines Agency recommends restricting use of cilostazol-containing medicines
Source: EMA Area: News Following a review of the current evidence, the European Medicines Agency's (EMA) Committee on Medicinal Products for Human Use (CHMP) has recommended that the use of cilostazol in the treatment of intermittent claudication should be restricted with a range of new measures aimed at targeting a patient population in which there are clinical benefits, and at the same time minimising important risks.   The Spanish Agency for Medicines and Health Products (AEMPS) asked the CHMP to carry out a review of cilostazol following a number of reports of serious suspected adverse effects, in particular ...
Source: NeLM - Cardiovascular Medicine - March 22, 2013 Category: Cardiology Source Type: news